2015年 大肠癌 社区讲课.pptVIP

  1. 1、本文档共63页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
目前的干预策略 一波未平一波又起 什么是肿瘤(癌症)? 如何应对? * * 颅脑肿瘤 头颈部肿瘤 肺癌 食道癌 肠癌 肝癌 膀胱癌、肾癌 前列腺癌 乳腺癌 胃癌 胰腺癌 妇科肿瘤 常见部位的恶性肿瘤 癌中之王? 癌王中王?? * 有害因素长期作用 不需要 不正常 破坏器官 危及生命 * 早期信号Ⅰ 新发肿块 黑痣破溃 进食梗阻 胃口变差 大便变细、黑便 * 早期信号Ⅱ 无痛性血尿 声音嘶哑 头痛伴呕吐 长期发热 绝经后再次出血(铁树开花) 工欲善其事必先利其器 * * * * * 干预手段 手术 根治手术、姑息手术 化疗 靶向治疗 放疗 三维适形、调强放疗 * * 靶向药物简介 易瑞沙、特罗凯 肺腺癌 力比泰(培美曲赛)肺腺癌、胸膜癌 安维汀、C225(爱彼妥)肠癌、头颈部 S1(替吉奥)胃癌 赫塞汀 乳腺癌、胃癌(HER2+) 多吉美 肝细胞癌、肾细胞癌 美罗华 NHL(CD20+) 格列卫 GIST、白血病 * 日费用 550(1天1片) * The widespread use of gefitinib allowed us to observe something that had not been commonly observed in the previous 20 years of treating non-small cell lung cancer. Some patients had near dramatic and even near complete responses with little toxicities and the duration could last a year of longer. This was fundamentally different than what had been previously observed. These responses were seen more frequently in women, patients with adenocarcinoma, and non-smokers. This was dramtically different than that seen with other types of treatment where these factors had relatively little difference in outcome. The second thing is that it was more commonly seen in patients from Japan (2-3 times more frequently) and the response rate to gefitinib treatment was reported to be 2-3 times as high in Japan as the United States and Europe. * The widespread use of gefitinib allowed us to observe something that had not been commonly observed in the previous 20 years of treating non-small cell lung cancer. Some patients had near dramatic and even near complete responses with little toxicities and the duration could last a year of longer. This was fundamentally different than what had been previously observed. These responses were seen more frequently in women, patients with adenocarcinoma, and non-smokers. This was dramtically different than that seen with other types of treatment where these factors had relatively little difference in outcome. The second thing is that it was more commonly seen in patients from Japan (2-3 times mor

文档评论(0)

peace0308 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档